1. Recent Funding
2. Investors
3. Invus

Invus has backed 3 companies on Recent Funding, 0 in the last 12 months; its most recent deal is Seaport Therapeutics (2024-10-21).

What Invus invests in

• Health and bio · 3 · 100%

How Invus invests

Share is of the 3 rounds on Recent Funding that name Invus. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

Company	Round with Invus	Total raised	Latest raise
SSeaport Therapeutics Health and bio	Oct 21, 2024 Series b+ · $225M	$325M	Oct 21, 2024 Series b+
LLifeMine Therapeutics Health and bio	Mar 23, 2022 Series b+ · $175M	$543M	Aug 6, 2026 Series b+
PParabilis Medicines Health and bio	Mar 1, 2021 Series b+ · $107M	$801M	Jan 8, 2026 Series b+

Most frequent co-investors

• AARCH Venture Partners2 shared rounds · last Oct 21, 2024
• GGV2 shared rounds · last Mar 23, 2022
• BBlue Pool Capital2 shared rounds · last Mar 23, 2022
• TT. Rowe Price1 shared round · last Oct 21, 2024
• GGeneral Atlantic1 shared round · last Oct 21, 2024
• CCPP Investments1 shared round · last Oct 21, 2024
• GGoldman Sachs Alternatives1 shared round · last Oct 21, 2024
• FForesite Capital1 shared round · last Oct 21, 2024
• SSofinnova Investments1 shared round · last Oct 21, 2024
• TThird Rock Ventures1 shared round · last Oct 21, 2024
• PPureTech Health1 shared round · last Oct 21, 2024
• FFidelity Management & Research Company1 shared round · last Mar 23, 2022

Portfolio companies are the companies on Recent Funding with a round that lists Invus, which is a subset of its real portfolio. API: /api/v1/investors/invus. All investors.